Equity Transactions (Tables)
|
9 Months Ended |
12 Months Ended |
Mar. 31, 2025 |
Jun. 30, 2024 |
Equity [Abstract] |
|
|
Schedule of summarizes the activity relating to the Company’s stock options |
Schedule of summarizes the activity relating to the Company’s stock options | |
| | | |
| | | |
| | | |
| | |
| |
Options | | |
Weighted- Average Exercise Price | | |
Weighted Remaining Average Contractual Term | | |
Aggregate Intrinsic Value | |
Outstanding at June 30, 2024 | |
| 518,076 | | |
$ | 54.11 | | |
| 6.1 | | |
$ | - | |
Options Granted | |
| 490,261 | | |
| 2.40 | | |
| 7.1 | | |
| - | |
Options Expired | |
| (38,806 | ) | |
| 62.48 | | |
| - | | |
| - | |
Options Canceled | |
| (82,402 | ) | |
| 7.87 | | |
| - | | |
| - | |
Outstanding at March 31, 2025 | |
| 887,129 | | |
$ | 29.46 | | |
| 6.2 | | |
$ | - | |
Exercisable at March 31, 2025 | |
| 448,470 | | |
$ | 44.50 | | |
| 5.1 | | |
$ | - | |
|
Schedule of summarizes the activity relating to the Company’s stock options | |
| | | |
| | | |
| | | |
| | |
| |
Options | | |
Weighted-Average Exercise Price | | |
Weighted Remaining Average Contractual Term | | |
Aggregate Intrinsic Value | |
Outstanding at June 30, 2022 | |
| 339,876 | | |
$ | 74.20 | | |
| 5.5 | | |
$ | - | |
Granted | |
| 71,467 | | |
| 59.00 | | |
| 8.6 | | |
| 38,610 | |
Options Expired | |
| (1,000 | ) | |
| 286.90 | | |
| - | | |
| - | |
Options Canceled | |
| (4,967 | ) | |
| 77.40 | | |
| | | |
| | |
Options Exercised | |
| (10,090 | ) | |
| 81.20 | | |
| - | | |
| - | |
Outstanding at June 30, 2023 | |
| 395,286 | | |
| 71.00 | | |
| 6.3 | | |
| 1,067,966 | |
Granted | |
| 155,242 | | |
| 11.70 | | |
| 9.8 | | |
| - | |
Options Expired | |
| (640 | ) | |
| 46.09 | | |
| - | | |
| - | |
Options Canceled | |
| (31,812 | ) | |
| 57.19 | | |
| - | | |
| - | |
Outstanding at June 30, 2024 | |
| 518,076 | | |
$ | 54.11 | | |
| 6.1 | | |
$ | - | |
Exercisable at June 30, 2024 | |
| 296,934 | | |
$ | 66.65 | | |
| 4.9 | | |
$ | - | |
|
Schedule of assumptions used |
Schedule of assumptions used |
|
|
|
|
March 31, 2025 |
|
March 31, 2024 |
Expected life of options (in years) |
4 |
|
5 |
Expected volatility |
93.44% |
|
87.11% |
Risk free interest rate |
4.34% |
|
4.80% |
Dividend Yield |
0% |
|
0% |
|
Schedule of assumptions used |
|
|
|
|
June 30, 2024 |
|
June 30, 2023 |
Expected life of options (in years) |
6 |
|
6 |
Expected volatility |
86.28% |
|
81.65% |
Risk free interest rate |
4.40% |
|
3.82% |
Dividend Yield |
0% |
|
0% |
|
Schedule of unvested of restricted stock units |
Schedule of unvested of restricted stock units | |
| | | |
| | |
| |
Number of Shares | | |
Weighted Average Grant Date Fair Value Per Share | |
| |
| | |
| |
Unvested at June 30, 2024 | |
| 40,291 | | |
$ | 44.59 | |
Issued | |
| 171,900 | | |
| 2.56 | |
Vested | |
| (74,643 | ) | |
| 11.67 | |
Canceled | |
| (28,509 | ) | |
| 6.67 | |
Unvested at March 31, 2025 | |
| 109,039 | | |
$ | 10.81 | |
|
Schedule of vesting of restricted common stock | |
| | | |
| | |
| |
Number of Shares | | |
Weighted Average Grant Date Fair Value Per Share | |
Unvested at June 30, 2022 | |
| 12,452 | | |
$ | 16.90 | |
Granted | |
| 68,711 | | |
| 58.87 | |
Vested | |
| (21,518 | ) | |
| 52.70 | |
Unvested at June 30, 2023 | |
| 59,646 | | |
$ | 52.40 | |
Issued | |
| 104,070 | | |
| 9.16 | |
Vested | |
| (122,395 | ) | |
| 16.94 | |
Canceled | |
| (1,030 | ) | |
| 61.20 | |
Unvested at June 30, 2024 | |
| 40,291 | | |
$ | 44.59 | |
|
Summary of warrants activity |
Summary of warrants activity | |
| | | |
| | | |
| | | |
| | |
| |
Number of Shares | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Life (Years) | | |
Aggregate Intrinsic Value | |
Outstanding and exercisable at June 30, 2024 | |
| 1,932,029 | | |
$ | 14.03 | | |
| 4.0 | | |
$ | - | |
Granted | |
| 10,181,640 | | |
| 1.65 | | |
| 4.8 | | |
| - | |
Exercised | |
| (2,502,967 | ) | |
| 1.53 | | |
| - | | |
| - | |
Expired | |
| (10,138 | ) | |
| 21.94 | | |
| - | | |
| - | |
Outstanding and exercisable at March 31, 2025 | |
| 9,600,564 | | |
$ | 3.50 | | |
| 4.3 | | |
$ | - | |
|
Summary of warrants activity | |
| | | |
| | | |
| | | |
| | |
| |
Number of Shares | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Life (Years) | | |
Aggregate Intrinsic Value | |
Outstanding and exercisable at June 30, 2022 | |
| 51,037 | | |
$ | 61.70 | | |
| 3.8 | | |
$ | - | |
Granted | |
| 727,273 | | |
| 18.20 | | |
| 5.0 | | |
| - | |
Expired | |
| (482 | ) | |
| 750.00 | | |
| - | | |
| - | |
Exercised | |
| (800 | ) | |
| 22.50 | | |
| - | | |
| - | |
Outstanding and exercisable at June 30, 2023 | |
| 777,029 | | |
| 20.60 | | |
| 4.0 | | |
| 18,318,954 | |
Granted | |
| 1,755,000 | | |
| 13.14 | | |
| 5.0 | | |
| - | |
Exercised | |
| (600,000 | ) | |
| 10.00 | | |
| - | | |
| - | |
Outstanding and exercisable at June 30, 2024 | |
| 1,932,029 | | |
$ | 14.03 | | |
| 4.0 | | |
$ | - | |
|
Schedule of warrants outstanding |
Schedule of warrants outstanding | |
| | |
| |
Number of Warrants | |
| |
| |
Expiring June 30, 2025 | |
| - | |
2026 | |
| 3,518 | |
2027 | |
| 36,100 | |
2028 | |
| 727,273 | |
2029 | |
| 1,155,000 | |
2030 | |
| 7,678,673 | |
Total outstanding warrants | |
| 9,600,564 | |
|
|